Hello, Fool! | Login | Signup | My Fool
Aug 29, 2008 12:08 AM ET | Site Changes | Help
The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.
View All Commentary (SNSS)
Recs
motleyjmw (< 20) Submitted: 1/19/07 1:48 PM : Start Price: $5.00 SNSS Score: -58.56
Biogen Idec is a beneficial owner
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK